Generate a structured brief — facts, issues, held, reasoning, and significance — for this case in seconds. Or browse the verbatim judgment via the source links below.
( Medicinal products for human use - Variation of the marketing authorisation for Tecfidera - Dimethyl fumarate, a medicinal product for human use - Directive 2001/83/EC - Article 14(11) of Regulation (EC) No 726/2004 - Article 266 TFEU )
European Commission, represented by L. Haasbeek, E. Mathieu and A. Spina, acting as Agents,
Biogen Netherlands BV, established in Amsterdam (Netherlands), represented by C. Schoonderbeek and B. Jong, lawyers,
composed, at the time of the deliberations, of R. da Silva Passos (Rapporteur), President, I. Reine and T. Pynnä, Judges,
having regard to the order of 2 February 2024, Zentiva and Zentiva Pharma v Commission (C‑609/23 P(R), not published, EU:C:2024:114),
Auto-extracted from BAILII. Full structured brief in progress — the source links below give you the verbatim judgment in the meantime.
Multiple official and mirror sources — pick whichever loads cleanly on your network.
Common Room
0 comments · About the Common Room →
No comments yet — start the discussion.
Voted-best comments help future students and feed Caselaw's AI study tools.